Teratoma testis handwritten

Reading File
What would you like on testicular teratoma?
  1. Handwritten-style short notes
  2. Handwritten-style detailed notes
  3. A handwritten-style image/poster
  4. Exam answer format

Create handwritten-style exam notes on testicular teratoma

Reading File
Finding Sources
Searching PubMed

testicular teratoma

Searching the Web

testicular teratoma pathology management clinical overview

Reading File
Reading File
Reading Web Page

https://www.ncbi.nlm.nih.gov/books/NBK567728

Generating Image

A single clean handwritten medical exam-notes page titled “TESTICULAR TERATOMA”. Use realistic legible blue-ink handwriting on faint ruled white notebook paper. Include compact headings and short bullets: Definition; Types (prepubertal benign vs postpubertal malignant potential); Clinical features; Tumour markers; Gross and microscopy; Spread and diagnosis; Management; Key exam points. Add a small simple hand-drawn cross-section of the testis in the margin. The spelling must be exact and all text highly readable.

Handwritten-style exam notes on testicular teratoma

Testicular teratoma - exam notes

Definition

A germ cell tumour (GCT) composed of differentiated somatic or organoid tissues derived from more than one germ layer: ectoderm, mesoderm, and endoderm.

Types and significance

FeaturePrepubertal typePostpubertal type
Typical settingInfants and childrenAdolescents and adults
Relationship to GCNISNot associatedUsually GCNIS-derived
i(12p) abnormalityAbsentUsually present
Biological behaviourUsually benignMalignant potential, even if histologically mature
OccurrenceOften pureOften part of a mixed NSGCT
High-yield point: In an adult testis, a “mature” teratoma must not be regarded as benign. Adult teratoma can metastasize, recur, and undergo somatic-type malignant transformation.
Robbins & Kumar Basic Pathology, p. 901.

Pathology

Gross
  • Well-circumscribed, often heterogeneous mass
  • Solid and cystic areas
  • May contain cartilage, bone, teeth, hair, skin-like tissue, or mucinous material
  • Hemorrhage/necrosis may occur in mixed malignant tumours
Microscopy
  • Tissues from two or three germ layers, arranged haphazardly:
    • Ectoderm: skin, neural tissue, squamous epithelium
    • Mesoderm: cartilage, bone, muscle, fat
    • Endoderm: respiratory or gastrointestinal epithelium, glands
  • May be mature or contain immature, commonly neuroectodermal, tissue.
  • Rarely develops somatic-type malignancy, for example sarcoma, adenocarcinoma, or squamous carcinoma.
    Robbins & Kumar Basic Pathology, p. 901.

Clinical features

  • Painless unilateral testicular swelling or mass
  • Heaviness or dull ache in the scrotum
  • Occasionally acute pain due to hemorrhage/infarction
  • Retroperitoneal nodal disease or distant metastases may cause back pain, cough, or constitutional symptoms.

Tumour markers

  • Pure teratoma: usually does not elevate AFP or beta-hCG.
  • Raised AFP suggests an associated yolk-sac tumour component.
  • Raised beta-hCG may indicate associated choriocarcinoma or syncytiotrophoblastic cells.
  • Obtain AFP, beta-hCG, and LDH before orchiectomy and use serial values for staging/follow-up.

Diagnosis and staging

  1. Scrotal ultrasonography: intratesticular, often heterogeneous cystic-solid lesion.
  2. Serum AFP, beta-hCG, LDH.
  3. Radical inguinal orchiectomy for diagnosis and primary treatment.
    • Do not perform trans-scrotal biopsy or scrotal orchiectomy.
  4. CT chest/abdomen/pelvis for staging.
  5. Histology determines pure versus mixed GCT and prepubertal versus postpubertal type.

Treatment

Prepubertal teratoma
  • Testis-sparing surgery may be considered for a benign-appearing lesion with normal markers and adequate residual normal testis.
  • Orchiectomy is used if malignancy cannot be excluded.
Postpubertal teratoma / NSGCT
  • Radical inguinal orchiectomy first.
  • Stage I disease: risk-adapted surveillance or retroperitoneal lymph-node dissection (RPLND) in selected cases.
  • Metastatic NSGCT: cisplatin-based chemotherapy when indicated, followed by resection of residual masses where appropriate.
  • Teratoma is relatively chemotherapy-resistant, so residual teratoma requires complete surgical excision when feasible.
  • Radiotherapy has no routine role.

Complication: growing teratoma syndrome

  • Enlarging metastatic masses during/after chemotherapy
  • Tumour markers normalize or fall
  • Resection specimen shows mature teratoma
  • Treatment: complete surgical excision, not additional chemotherapy.

One-line viva answer

Testicular teratoma is a nonseminomatous germ-cell tumour containing differentiated tissues from multiple germ layers; it is usually benign in the prepubertal type but has malignant potential in postpubertal patients regardless of whether the tissue appears mature.
The distinction between prepubertal indolent lesions and postpubertal GCNIS-related teratoma is also summarized in the NIH clinical overview.

Seminoma handwritten

Reading File
Finding Sources
Searching PubMed

testicular seminoma

Searching the Web

testicular seminoma diagnosis treatment overview NCI

Generating Image

A single clean handwritten medical exam-notes page titled “SEMINOMA (Testis)”. Use realistic highly legible blue-ink handwriting on faint ruled white notebook paper. Include compact correct exam bullets: Definition: malignant germ-cell tumour, most common testicular GCT, peak 30–40 years. Risk factors: cryptorchidism, gonadal dysgenesis, family history. Clinical: painless testicular enlargement. Gross: homogeneous pale grey-white fleshy mass, no hemorrhage or necrosis. Microscopy: sheets/lobules of uniform large cells with clear glycogen-rich cytoplasm, central nuclei and prominent nucleoli; fibrous septa with lymphocytes; may have granulomas. Markers: AFP normal; beta-hCG mildly elevated in some cases due to syncytiotrophoblasts; LDH. Spread: lymphatic to para-aortic nodes. Diagnosis: ultrasound, markers, radical inguinal orchiectomy, CT staging. Treatment: stage I surveillance preferred; radiotherapy or carboplatin selected cases; advanced disease cisplatin chemotherapy. Prognosis excellent, highly radiosensitive and chemosensitive. Add a small neat hand-drawn testis and a small microscopic cell sketch in margins. All text must be readable and spelling exact.

Handwritten-style exam notes: Seminoma

Seminoma - handwritten-style exam notes

Definition

  • Seminoma is the most common pure testicular germ-cell tumour.
  • It is a malignant tumour arising from germ-cell neoplasia in situ (GCNIS).
  • Typically affects men aged 30-40 years.

Risk factors

  • Cryptorchidism
  • Gonadal dysgenesis
  • Family history of testicular germ-cell tumour
  • Prior germ-cell tumour in the opposite testis

Clinical features

  • Painless enlargement or a firm testicular mass
  • Feeling of testicular heaviness or dull ache
  • Occasionally back pain from retroperitoneal lymph-node metastasis
  • Gynecomastia is uncommon and may occur if beta-hCG is elevated.

Gross morphology

  • Well-defined, homogeneous, pale gray-white, fleshy mass
  • Usually no hemorrhage or necrosis
  • Large lesions may rarely show necrosis

Microscopy

  • Sheets or lobules of large uniform polygonal cells
  • Clear, glycogen-rich cytoplasm with distinct cell borders
  • Central round nucleus and prominent nucleolus
  • Fibrous septa containing dense lymphocytic infiltrate
  • Granulomatous reaction may occur
  • Occasional syncytiotrophoblasts can be present.

Tumour markers

  • AFP: always normal in pure seminoma
    • Raised AFP indicates an associated nonseminomatous component until proved otherwise.
  • beta-hCG: mildly elevated in about 10%-15% due to syncytiotrophoblasts.
  • LDH: may reflect tumour burden.

Spread

  • Spreads mainly through lymphatics.
  • First involves para-aortic/retroperitoneal lymph nodes.
  • Hematogenous spread occurs later, commonly to lungs, liver, bone, or brain.

Diagnosis

  1. Scrotal ultrasound
  2. Serum AFP, beta-hCG, and LDH
  3. Radical inguinal orchiectomy for diagnosis and primary treatment
  4. CT of chest, abdomen, and pelvis for staging
  5. Avoid trans-scrotal biopsy.

Treatment

  • Stage I: radical inguinal orchiectomy followed mainly by active surveillance.
  • Selected stage I cases: adjuvant carboplatin or para-aortic radiotherapy.
  • Stage IIA/IIB: radiotherapy or cisplatin-based chemotherapy, depending on nodal burden and clinical factors.
  • Advanced or bulky disease: cisplatin-based combination chemotherapy.

Prognosis

  • Highly radiosensitive and chemosensitive.
  • Excellent cure rate, including in advanced disease.
  • Stage I disease has a cure rate approaching 100% with appropriate management, as summarized by the NCI treatment guidance.
Exam pearl:
A homogeneous gray-white testicular tumour with clear cells, fibrous septa, and lymphocytes is seminoma. AFP must remain normal in pure seminoma.
Robbins & Kumar Basic Pathology, p. 655.
This is a shared conversation. Sign in to Orris to start your own chat.